跳至主要内容
临床试验/JPRN-UMIN000031734
JPRN-UMIN000031734招募中未知

Japanese Pediatric Leukemia/Lymphoma Study Group Prospective observational study of relapsed/refractory pediatric acute myeloid leukemia - JPLSG-AML-R15

Japanese Pediatric Leukemia/Lymphoma Study Group0 个研究点目标入组 160 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
1years-old 至 25years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Additional or multiple relapsed patients Patients with secondary acute myeloid leukemia

研究者

发起方
Japanese Pediatric Leukemia/Lymphoma Study Group

相似试验

已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-B12: A Multi-Center Phase II/III Study in Children with Newly Diagnosed B-cell Precursor Acute Lymphoblastic LeukemiaB cell precursor Acute Lymphoblastic Leukemia
JPRN-UMIN000009339Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)1,940
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid LeukemiaAcute myeloid Leukemia Myelodysplastic syndrome
JPRN-UMIN000000989Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)73
已完成
不适用
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) CML-08: A Multi-Center Observational Study for Children with Chronic Phase of Chronic Myeloid LeukemiaChronic Phase of Chronic Myeloid Leukemia (CML) in children
JPRN-UMIN000002581Japanese Pediatric Leukemia/Lymphoma Study Group22
招募中
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-T11 and Japan Adult Leukemia Study Group (JALSG) T-ALL-211-U ALL-T11: A Multi-Center Phase II Study in Children and Adolescence with Newly Diagnosed T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Leukemia
JPRN-UMIN000006851Japanese Pediatric Leukemia/Lymphoma Study Group147
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-R11: Multi-center Phase II Study of the efficacy and the safety in the induction chemotherapy containing fludarabine for children with the first bone marrow relapse and induction failure of acute myeloid leukemia.acute myeloid leukemia
JPRN-UMIN000007390Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)50